Rosuvastatin Completed Phase 3 Trials for Dyslipidemia (Fredrickson Type Ⅱa) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03571087Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
NCT02445352Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
NCT01078675An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
NCT00355615PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin